Associations of cardiometabolic multimorbidity with all-cause dementia, alzheimer's disease, and vascular dementia: a cohort study in the UK biobank
- PMID: 40624483
- PMCID: PMC12232823
- DOI: 10.1186/s12889-025-23352-5
Associations of cardiometabolic multimorbidity with all-cause dementia, alzheimer's disease, and vascular dementia: a cohort study in the UK biobank
Abstract
Background: Cardiometabolic diseases (CMDs) including type 2 diabetes, heart disease, and stroke, increase the risk of dementia. However, the correlation between CMDs and dementia in different subgroups and the underlying pathophysiological mechanisms linking CMDs with dementia warrant further investigation.
Methods: This prospective cohort study included a total of 287,748 individuals from the UK Biobank. The outcome measures included all-cause dementia (ACD), Alzheimer's disease (AD) and vascular dementia (VD). Cox regression models and subgroup analyses were used to assess the association between CMD status and dementia, while mediation analysis was evaluated potential roles of inflammatory/metabolic markers in the observed associations.
Results: Compared with those without CMD, those with CMD multimorbidity had an elevated risk of ACD (hazard ratio [HR]: 2.27, 95% confidence interval [95% CI]: 1.95-2.63), AD (HR: 1.49, 95% CI: 1.13-1.97), and VD (HR: 3.70, 95% CI: 2.93-4.69). According to the subgroup analyses, the positive correlations between CMDs and ACD, as well as AD, were stronger in individuals who were under the age of 60 or female. Mediation analysis indicated that neutrophils mediated 2.43% of the association of CMDs with ACD, while glucose and hemoglobin A1c mediated 9.22% and 11.85% of the association of CMDs with ACD, respectively.
Conclusion: This study further expands the research on cardiometabolic multimorbidity and dementia, highlighting the need for focused attention on specific populations, such as younger individuals and women. Additionally, inflammatory and metabolic biomarkers, as potential mediators, provide critical insights into the complex pathophysiological mechanisms.
Keywords: Cardiometabolic disease; Dementia; Inflammation; Metabolism.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). The UK biobank was approved by the Northwest Multicenter Research Ethics Committee (11/NW/0382), and all participants agreed to their inclusion, and signed written informed consent forms. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank.Cardiovasc Diabetol. 2025 Jun 18;24(1):257. doi: 10.1186/s12933-025-02819-0. Cardiovasc Diabetol. 2025. PMID: 40533754 Free PMC article.
-
Association between metabolic-associated fatty liver disease and risk of cardiometabolic multimorbidity: a disease trajectory analysis in UK Biobank.Front Endocrinol (Lausanne). 2025 Jun 18;16:1585725. doi: 10.3389/fendo.2025.1585725. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40607218 Free PMC article.
-
Anti-Inflammatory Diet and Dementia in Older Adults With Cardiometabolic Diseases.JAMA Netw Open. 2024 Aug 1;7(8):e2427125. doi: 10.1001/jamanetworkopen.2024.27125. JAMA Netw Open. 2024. PMID: 39133488 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Nimodipine for primary degenerative, mixed and vascular dementia.Cochrane Database Syst Rev. 2001;(1):CD000147. doi: 10.1002/14651858.CD000147. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2002;(3):CD000147. doi: 10.1002/14651858.CD000147. PMID: 11279679 Updated.
References
-
- Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet. 2024;404(10452):572–628. - PubMed
-
- Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and alzheimer’s disease. Arch Med Res. 2012;43(8):600–8. - PubMed
-
- Dove A, Shang Y, Xu W, Grande G, Laukka EJ, Fratiglioni L, et al. The impact of diabetes on cognitive impairment and its progression to dementia. Alzheimers Dement. 2021;17(11):1769–78. - PubMed
-
- Wolters FJ, Segufa RA, Darweesh SKL, Bos D, Ikram MA, Sabayan B, et al. Coronary heart disease, heart failure, and the risk of dementia: A systematic review and meta-analysis. Alzheimers Dement. 2018;14(11):1493–504. - PubMed
MeSH terms
Grants and funding
- 21623316/the Fundamental Research Funds for Central Universities
- 21623316/the Fundamental Research Funds for Central Universities
- 2024A04J4175/the Guangzhou Science and Technology Project - Basic and applied basic research
- 2023A04J1913/the Guangzhou Science and Technology Project - Basic and applied basic research
- 82201438/the National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Medical